211. Hypoplastic left heart syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 22 / Drugs : 29 - (DrugBank : 9) / Drug target genes : 5 - Drug target pathways : 14
Hypoplastic left heart syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 211 | Hypoplastic left heart syndrome | - |
| 13 | Multiple sclerosis/Neuromyelitis optica | 5.000 |
| 85 | Idiopathic interstitial pneumonia | 5.000 |
| 86 | Pulmonary arterial hypertension | 5.000 |
| 84 | Sarcoidosis | 3.239 |
| 51 | Scleroderma | 3.228 |
| 212 | Tricuspid atresia | 2.250 |
| 210 | Single Ventricle | 1.913 |
| 41 | Giant cell arteritis | 1.909 |
| 66 | IgA nephropathy | 1.903 |
| 78 | Hypopituitarism | 1.882 |
| 113 | Muscular dystrophy | 1.861 |
| 49 | Systemic lupus erythematosus | 1.832 |
| 96 | Crohn disease | 1.821 |
| 2 | Amyotrophic lateral sclerosis | 1.821 |
| 46 | Malignant rheumatoid arthritis | 1.819 |
| 83 | Addison disease | 1.200 |
| 47 | Buerger disease | 1.200 |
| 220 | Rapidly progressive glomerulonephritis | 1.000 |
| 30 | Distal myopathy | 1.000 |
| 81 | Congenital adrenal hyperplasia | 1.000 |